Accelerating Business Collaboration in Japan’s Regenerative Medicine Sector

The Japan External Trade Organization (JETRO) has launched the Japan Entry Acceleration Program (JEAP) 2026, aimed at fostering collaboration between global companies and Japan’s regenerative medicine sector. This initiative is crucial for foreign entrepreneurs looking to tap into Japan’s innovative healthcare market, providing a structured pathway for business entry and collaboration. With Japan’s aging population and strong emphasis on medical advancements, this program presents a unique opportunity for foreign businesses to establish a foothold in a rapidly growing industry.

Background & Context

The Japan Entry Acceleration Program (JEAP) 2026 is a strategic initiative by the Japan External Trade Organization (JETRO) to enhance Japan’s position in the global regenerative medicine market. This program is designed to attract foreign companies to collaborate with Japanese firms and research institutions, thereby accelerating innovation and commercialization in this vital sector. The Japanese government has been actively promoting regenerative medicine through various policies and funding initiatives, particularly following the enactment of the Act on the Safety of Regenerative Medicine (Shinsei Iryō no Anzen ni Kansuru Hōritsu) in 2014, which was last amended in 2021. This act provides a regulatory framework for the development and approval of regenerative medicine products, ensuring safety and efficacy while encouraging investment. The JEAP program is part of a broader effort to position Japan as a leader in this field, especially as global demand for regenerative therapies increases. The program is open for applications from July 1, 2026, and aims to facilitate partnerships that can lead to groundbreaking advancements in healthcare.

How This Affects Your Business in Japan

Item	Cost (JPY)	Cost (USD approx)	Notes
Company Registration	¥150,000	$1,000	Standard registration fee
Notary Fee	¥50,000	$350	For document notarization
Visa Application	¥4,000	$30	Business Manager visa

1. Foreign Residents Already Operating a Business in Japan
For existing foreign businesses in Japan, participating in the JEAP can provide access to valuable resources, networks, and potential partnerships with local firms. It is advisable to prepare a comprehensive business proposal highlighting your company’s strengths and how they align with the goals of the program. The application process typically requires documentation such as a business plan, financial statements, and proof of prior collaborations or projects. The deadline for applications is typically set for late August 2026, and failure to apply could mean missing out on significant opportunities for growth and innovation.

2. Foreign Nationals Planning to Establish a New Company
For foreign entrepreneurs looking to start a new business in Japan, the JEAP offers a structured entry point into the regenerative medicine sector. Interested parties should gather necessary documents, including a business plan, proof of funding, and any relevant certifications or licenses. Engaging with JETRO early in the process can provide guidance and support, as they offer English-language assistance. The application deadline is crucial, and missing it could delay your entry into the market significantly.

3. Foreign Investors Who Are NOT Residents of Japan
For foreign investors, the JEAP represents an opportunity to identify and invest in promising Japanese startups and established firms in the regenerative medicine field. Investors should conduct thorough due diligence on potential investment targets and prepare to present their investment strategy to JETRO. The program may also facilitate introductions to key stakeholders in the industry. Not participating could result in missed investment opportunities in a rapidly evolving market.

Step-by-Step: What You Need to Do

Step 1: Research the JEAP program
Visit the JETRO website to understand the program details and eligibility criteria. JETRO provides English support for inquiries.
Office: JETRO (English Support: Yes)
Cost: Free (¥0)
Time: 1 week
Pitfall: Overlooking eligibility criteria

Step 2: Prepare your business proposal
Draft a comprehensive business proposal that outlines your objectives, potential contributions, and alignment with the regenerative medicine sector. Seek feedback from industry experts if possible.
Office: N/A (English Support: N/A)
Cost: Varies
Time: 2-4 weeks
Pitfall: Lack of clear alignment with program goals

Step 3: Gather required documentation
Collect necessary documents such as financial statements, business plans, and proof of previous collaborations. Ensure all documents are translated into English if required.
Office: Translation Service (English Support: Yes)
Cost: ¥30,000 (~$200 USD)
Time: 2 weeks
Pitfall: Incomplete documentation

Step 4: Submit your application
Apply through the JETRO online portal before the application deadline, typically in late August 2026. Ensure all documents are complete to avoid delays.
Office: JETRO (English Support: Yes)
Cost: Free (¥0)
Time: 1 week
Pitfall: Missing the deadline

Step 5: Engage with JETRO
After submission, maintain communication with JETRO for any follow-up questions or additional requirements. They offer English support throughout the process.
Office: JETRO (English Support: Yes)
Cost: Free (¥0)
Time: Ongoing
Pitfall: Lack of follow-up

Step 6: Prepare for potential interviews
Be ready for interviews or discussions with JETRO or potential partners. Prepare to articulate your business vision and how it aligns with the program.
Office: JETRO (English Support: Yes)
Cost: Free (¥0)
Time: 1 week
Pitfall: Unclear business vision

Key Contacts
www.jetro.go.jp/en/
www.moj.go.jp/isa/
www.customs.go.jp/english/
www.nta.go.jp/english/
www.meti.go.jp/english/

Expert Analysis: Japan vs. Regional Competitors

Metric	Japan	Singapore	Hong Kong	South Korea
Incorporation Time	14 days	3 days	5 days	10 days
Minimum Capital Requirement	¥0	S$1	HK$1	₩100,000
Annual Filing Cost	¥60,000	S$300	HK$2,000	₩50,000
Corporate Tax Rate	30%	17%	16.5%	22%

What to Expect Next

Looking ahead, it is essential to monitor the developments surrounding the JEAP program and any potential amendments to the Act on the Safety of Regenerative Medicine. As the program progresses, additional funding opportunities and partnerships may emerge, particularly as Japan seeks to solidify its position as a leader in regenerative medicine. Stakeholders should keep an eye on announcements from JETRO and related government agencies for updates on application timelines and new initiatives aimed at enhancing foreign investment in this sector.

---

Sources & References

This article is based on the following source and enhanced with professional analysis for foreign business owners.
Source: 再生医療分野のグローバル企業との事業共創加速アクセラレーションプログラム 「Japan Entry Acceleration Program（JEAP）2026」企業募集開始

⚠️ This article is for informational purposes only and does not constitute legal advice. Please consult a qualified Japanese attorney (bengoshi) or judicial scrivener (shiho shoshi) for advice specific to your situation.